Genespire Secures €16 Million Series A Financing from Sofinnova Partners to Advance Transformative Gene Therapies
Biotech executive, Julia Berretta, Ph.D., is named Chief Executive Officer MILAN, Italy–(BUSINESS WIRE)– Genespire, a biotechnology company focused on the development of transformative gene therapies...